Keytruda (pembrolizumab)

pCPA File Number: 20927

Negotiation Status:

Concluded with an LOI

Indication(s):

Non-small Cell Lung Cancer

Sponsor/Manufacturer:

Merck Canada Inc.

CADTH Project Number:

pCODR 10077

pCPA Engagement Letter Issued:

2017-01-30

Negotiation Process Concluded:

2017-11-01